Clinical Trials
2 trialsNCT06390826 2026-05-28
Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT00514137 2014-05-28
Sunitinib in Treating Patients With Relapsed Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed